Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

A Prospective Evaluation of Postoperative Opioid Use in Otologic Surgery. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology Qian, Z. J., Alyono, J. C., Woods, O. D., Ali, N. n., Blevins, N. H. 2019

Abstract

To prospectively evaluate opioid consumption following adult outpatient otologic surgery.Prospective observational.Single-tertiary referral center.Patients scheduled for otologic surgery who did not have a history of chronic opioid use were recruited between February 2018 and February 2019.Opioid consumption was queried using telephone or in-person surveys administered between postoperative days 5 and 15. Patient demographics, surgical details, and opioid prescription patterns were abstracted from medical records. Opioid distribution was determined by querying records maintained by the California Department of Justice through a state-wide prescription drug monitoring program mandated since 2016.Seventy patients were prescribed an average of 68.9?±?31.8?mg of morphine equivalents (MME) and consumed 47.3?±?42.9 MME over 2.4?±?2.3 days postoperatively. Patients who received a postauricular incision were prescribed significantly more than those who underwent transcanal procedures (86.2 vs 55.9 MME; t test, p?

View details for DOI 10.1097/MAO.0000000000002364

View details for PubMedID 31469798